In plain English
IDNA is a biotech company that has seen a 13% intraday gain after news of a positive Phase 3 mRNA cancer trial involving Merck and…
Company stock · USD
IDNA
$40.91
Today
−$0.13-0.32%
vs yesterday’s close
Live price
Price chart Pro
Company briefing
Plain English context — why the name shows up in the news, and what to watch next.
IDNA is a biotech company that has seen a 13% intraday gain after news of a positive Phase 3 mRNA cancer trial involving Merck and…
Latest on this name
1 recent card — open any for the full deeper dive.
The first positive Phase 3 mRNA cancer trial may revive the mRNA investment thesis beyond COVID and boost precision‑medicine ETFs.
Company reports
No filings here yet
Official report cards for IDNA will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.